Vimarsana
Biggest News Aggregation in the World

Maria Backlund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maria Backlund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maria Backlund Today - Breaking & Trending Today

AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ... - Vimarsana News

AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...

AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...

AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024 - Vimarsana News

AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that an abstract on its preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions has been accepted for presen...

New Article on Disease Modifying Data with NeuroRestore ACD856 against Alzheimer's now Available Online - Vimarsana News

New Article on Disease Modifying Data with NeuroRestore ACD856 against Alzheimer's now Available Online

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that a new scientific article on preclinical results supporting a disease-modifying effect with NeuroRestore ACD856 has been made available online.

Source: yahoo.com
AlzeCure Pharma: AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential Disease-Modifying Effect of NeuroRestore ACD856 - Vimarsana News

AlzeCure Pharma: AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential Disease-Modifying Effect of NeuroRestore ACD856

STOCKHOLM, SWEDEN / ACCESSWIRE / March 30, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential ... 2023-03-30 - Vimarsana News

AlzeCure Presents New Data at Alzheimer's Conference AD/PD on the Potential ... 2023-03-30

AlzeCure Presents New Data at Alzheimer’s Conference AD/PD on the Potential ...